For this, we extended our study to two different cancer cell lines known for their differential expression of ACE2, the highly ACE2-expressing (HT-29 colon cancer) and ACE2 non-expressing (HeLa cervix adenocarcinoma) cells. This evidence concerns the gene ACE2 and malignant colon neoplasm.